* UK’s CMA says decided not to refer merger by Mckesson Corp unit AAH Pharmaceuticals of
MASTA and Sangers to a Phase 2 investigation.
Source text for Eikon: (http://bit.ly/29eSv3J)
(Bengaluru…
The post BRIEF-UK’s CMA says not refer Mckesson unit, AAH Pharma-UDG deal for phase 2 probe appeared first on NASDAQ.